文传商讯

CORRECTING and REPLACING KATE, Japan’s No. 1 Makeup Brand, Launches Strategic Initiatives to Streng
2025-07-15 16:11:38

Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narco
2025-07-15 16:11:38